PCM
ANGO icon

Peregrine Capital Management’s AngioDynamics ANGO Stock Holding History

Peregrine Capital Management’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-553,314
Closed -$9.2M – 253
2017
Q4 		$9.2M Buy
553,314
+2,520
+0.5% +$43K 0.22% 186
2017
Q3 		$9.41M Sell
550,794
-197,693
-26% -$3.32M 0.23% 187
2017
Q2 		$12.1M Buy
+748,487
New +$11.8M 0.3% 134

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Peregrine Capital Management's ANGO Position: Q1 2018 in Review

Peregrine Capital Management sold out of AngioDynamics (ANGO) in Q1 2018, closing a stake of 553,314 shares — an estimated $9.2M sold.

Peregrine Capital Management first reported a position in ANGO in Q2 2017 and held it in 3 quarters. The position peaked at $12.1M in Q2 2017. 164 funds tracked by Wall St. Rank hold ANGO as of Q1 2018.

  • Peregrine Capital Management reported no remaining AngioDynamics position as of Q1 2018 after selling out during the quarter.
  • Peregrine Capital Management sold 553,314 AngioDynamics shares in Q1 2018, an estimated $9.2M.
  • Peregrine Capital Management first reported a position in AngioDynamics in Q2 2017 and held it in 3 quarters.
  • Peregrine Capital Management's AngioDynamics position peaked at $12.1M in Q2 2017.
  • 164 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2018.

Based on Peregrine Capital Management's 13F filing for Q1 2018, filed 16 Apr 2018.